BioCryst Pharmaceuticals
BCRX
#4608
Rank
NZ$2.72 B
Marketcap
$13.17
Share price
2.39%
Change (1 day)
3.05%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$1.32 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is NZ$1.32 B. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$1.30 B11.73%
2022-12-31NZ$1.16 B34.82%
2021-12-31NZ$0.86 B122.9%
2020-12-31NZ$0.38 B209.68%
2019-12-31NZ$0.12 B36.22%
2018-12-31NZ$92.12 M19.56%
2017-12-31NZ$77.05 M-0.65%
2016-12-31NZ$77.55 M75.69%
2015-12-31NZ$44.14 M15.43%
2014-12-31NZ$38.24 M4.69%
2013-12-31NZ$36.52 M-0.18%
2012-12-31NZ$36.59 M-4.8%
2011-12-31NZ$38.43 M
2000-12-31NZ$0.02 M
1997-12-31NZ$0.17 M-59.42%
1996-12-31NZ$0.42 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$1.20 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.21 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.42 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.37 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.74 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.85 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.65 B 2,508.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.39 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.61 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA